Valuation: Carlsmed, Inc.

Market Cap 390M 346M 323M 294M 555M 37.45B 561M 3.91B 1.52B 19.15B 1.46B 1.43B 61.45B P/E 2026 *
-9.58x
P/E 2027 * -9.76x
Enterprise Value 390M 346M 323M 294M 555M 37.45B 561M 3.91B 1.52B 19.15B 1.46B 1.43B 61.45B EV / Sales 2026 *
5.08x
EV / Sales 2027 * 3.6x
Free-Float
55.41%
Yield 2026 *
-
Yield 2027 * -
1 day+3.71%
1 week-5.50%
Current month+1.42%
1 month-12.67%
3 months+25.84%
6 months+46.66%
Current year+15.55%
1 week 13.45
Extreme 13.45
14.88
1 month 13.45
Extreme 13.45
15.88
Current year 8.5
Extreme 8.5
17.23
1 year 8.5
Extreme 8.5
17.23
3 years 8.5
Extreme 8.5
17.23
5 years 8.5
Extreme 8.5
17.23
10 years 8.5
Extreme 8.5
17.23
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 50 2018-06-03
Chief Executive Officer 50 2018-06-03
Director of Finance/CFO 55 2026-09-27
Director TitleAgeSince
Chairman 50 2018-06-03
Director/Board Member 50 2018-06-03
Director/Board Member 66 2020-12-15
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 Free

Chief Financial Officer

269,423 1.0136%
9/24/26 Other

General Counsel

146,222 0.5501%
9/8/26 Free

Chief Operating Officer

50,000 0.1881%
Change 5-day change 1-year change 3-year change Capi.($)
+3.71%-5.50%+7.05% - 390M
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average +0.14%-1.32%-8.68%+12.44% 69.06B
Weighted average by Cap. +0.03%-1.30%-16.35%+10.13%

Financials

2026 *2027 *
Net sales 76.71M 68.16M 63.62M 57.98M 109M 7.37B 110M 770M 298M 3.77B 288M 282M 12.1B 108M 96.05M 89.65M 81.71M 154M 10.39B 156M 1.08B 420M 5.31B 406M 397M 17.05B
Net income -40.36M -35.86M -33.47M -30.51M -57.54M -3.88B -58.07M -405M -157M -1.98B -152M -148M -6.37B -40.07M -35.6M -33.23M -30.29M -57.12M -3.85B -57.65M -402M -156M -1.97B -150M -147M -6.32B
Net Debt - -
Logo Carlsmed, Inc.
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Employees
127
Date Price Change Volume
26-10-02 US$14.27 +3.71% 151,651
26-10-01 US$13.76 -2.20% 158,841
26-09-30 US$14.07 -0.14% 56,797
26-09-29 US$14.09 -0.63% 53,833
26-09-28 US$14.18 -6.09% 52,942
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.27USD
Average target price
19.20USD
Spread / Average Target
+34.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CARL Stock